DBV Technologies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch DBVT and buy or sell other stocks, ETFs, and their options commission-free!About DBVT
DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients.
CEODaniel Tassé
CEODaniel Tassé
Employees109
Employees109
HeadquartersChatillon, Hauts-de-France
HeadquartersChatillon, Hauts-de-France
Founded2002
Founded2002
Employees109
Employees109
DBVT Key Statistics
Market cap472.39M
Market cap472.39M
Price-Earnings ratio-2.74
Price-Earnings ratio-2.74
Dividend yield—
Dividend yield—
Average volume212.33K
Average volume212.33K
High today$16.95
High today$16.95
Low today$15.75
Low today$15.75
Open price$16.81
Open price$16.81
Volume223.66K
Volume223.66K
52 Week high$18.00
52 Week high$18.00
52 Week low$2.20
52 Week low$2.20
DBVT News
TipRanks 3d
Optimistic Outlook for DBV Technologies Amid Promising Viaskin Peanut AdvancementsIn a report released today, Sam Slutsky from LifeSci Capital maintained a Buy rating on DBV Technologies SA – American, with a price target of $19.00. Elevate Y...
Analyst ratings
83%
of 6 ratingsBuy
83.3%
Hold
0%
Sell
16.7%